← Back to Search

Swallowing Assist Device

Swallowing Expansion Device for Oropharyngeal Dysphagia

N/A
Waitlist Available
Led By Peter Belafsky, MD PhD
Research Sponsored by Peter Belafsky, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before implantation, 2 months and 2 years post implantation
Awards & highlights

Study Summary

This trial will test whether the Swallow Expansion Device is safe for humans.

Eligible Conditions
  • Oropharyngeal Dysphagia
  • Swallowing Difficulty

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before implantation, 2 months and 2 years post implantation
This trial's timeline: 3 weeks for screening, Varies for treatment, and before implantation, 2 months and 2 years post implantation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Upper Esophageal Sphincter (UES) Opening
Secondary outcome measures
Change in Penetration Aspiration Scale (PAS)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Swallowing Expansion DeviceExperimental Treatment1 Intervention
Titanium swallowing expansion device

Find a Location

Who is running the clinical trial?

Peter Belafsky, MDLead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
Peter Belafsky, MD PhDPrincipal Investigator - University of California, Davis
Shriners Hospitals for Children-Northern California, University of California-Davis Medical Center
Tulane University School Of Medicine (Medical School)
Tulane University School Of Medicine (Residency)
~0 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top